FIELD: pharmacology.
SUBSTANCE: compositions (versions) for enteral use for treatment and/or prevention of disturbed ketone and lactate metabolism, i.e. increased concentrations of ketone bodies, lactate and/or other organic acids of a mammal suffering from hyperglycemia after fasting or after eating, resistance to insulin or diabetes, comprising 12-40 wt % of aspartate equivalents in the protein fraction of vegetable and animal proteins in combination with vitamin B12.
EFFECT: improved glucose and insulin response in blood, and restoration of the glucose and fatty acid metabolism balance.
19 cl, 2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PREPARATION FOR ASPARTATE APPLICATION FOR BLOOD GLUCOSE LEVELS CONTROL | 2005 |
|
RU2402243C2 |
KETOGENIC DIET | 2007 |
|
RU2433748C2 |
PREVENTION OR TREATMENT OF EXCESS WEIGHT AND OBESITY FOR PATIENTS WITH TYPE 2 DIABETES | 2011 |
|
RU2619223C2 |
TREATMENT OF TRAUMATIC BRAIN INJURY | 2018 |
|
RU2771277C2 |
LOW-PROTEIN INFANT FOOD WITH INCREASED INDISPENSABLE AMINO ACIDS CONTENT | 2011 |
|
RU2559432C2 |
NUTRITIONAL COMPOSITION PROMOTING NORMAL DEVELOPMENT AND GROWTH | 2009 |
|
RU2501553C2 |
APPLICATION OF NUTRITIVE COMPOSITIONS FOR DISEASES PREVENTION | 2007 |
|
RU2444912C2 |
LEUCINE-ENRICHED COMPOSITION | 2006 |
|
RU2428977C2 |
APPLICATION OF NUTRIENT COMPOSITION FOR MUSCULAR FUNCTION AND DAILY ACTIVITY IMPROVEMENT | 2009 |
|
RU2636162C2 |
ENDOGENIC TGF-BETA PRESERVATION METHODS | 2009 |
|
RU2547590C2 |
Authors
Dates
2017-10-11—Published
2005-07-18—Filed